MEDICAL IP was founded in South Korea in 2015 and back by some of the most leading medical institution in the world. Having been acknowledged and supported by Seoul National University and its Hospital.
We continue our research and development to be based in Cancer Research Institute, SNUH, Seoul, and expanding headquarters centers in Palo Alto in Global Business Institutions, Plug and Play Tech Center, California, USA.
Medical IP unveils world's first quantitative COVID-19 SW - 2020.05.29
COVID-19 Pandemic is experiencing unprecedented medical resource shortages around the world. In a number of countries, medical staff and medical facilities have reached their limits as the number of confirmed patients has increased rapidly. The number of deaths is rapidly increasing as prompt treatment is not possible. Among these, MEDIP COVID19 developed by Medical IP is presenting the optimal solution to efficiently utilize medical resources. (Hereinafter omitted)